20 January 2018
News and Views
Links and Services
A study in the latest issue of Helicobacter reports a greater than 95% success with 14-day bismuth quadruple anti-Helicobacter pylori therapy.
A combination capsule of bismuth, metronidazole, and tetracycline plus omeprazole given as 10-day
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors